We demonstrated in an independent cohort of BC patients18 that, unlike the refractory signature, the sensitive signature score was significantly higher (P = 0.0037) in monocytes with a high IFN signature score (Figure 6f). This evidence concerns the gene IFNA1 and breast cancer.